Indolent B-Cell lymphomas associated with HCV infection: Clinical and virological features and role of antiviral therapy

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Arcaini, Luca ^a   Merli, Michele ^b   Volpetti, Stefano ^c   Rattotti, Sara ^a   Gotti, Manuel ^a   Zaja, Francesco ^c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; BOCEPREVIR; INTERFERON; PEGINTERFERON; PROTEINASE INHIBITOR; RIBAVIRIN; RITUXIMAB; TELAPREVIR; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; B CELL LYMPHOMA; CLINICAL FEATURE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; HEPATITIS C; HISTOLOGY; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT PLANNING; TREATMENT RESPONSE; VIROLOGY; WALDENSTROEM MACROGLOBULINEMIA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; HEPATITIS C; HUMANS; LYMPHOMA, B-CELL; TREATMENT OUTCOME;

EID: 84866131563     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/638185     Document Type: Review

References (83)

1. Gribben J. G., How I treat indolent lymphoma. Blood 2007 109 11 4617 4626 2-s2.0-34249726129 10.1182/blood-2006-10-041863 (Pubitemid 46830597)
2. Isaacson P. G., Piris M. A., Berger F., Swerdlow S. H., Thieblemont C., Pittaluga S., Harris N. L., Swerdlow S., Campo E., Harris N. L., Splenic B-cell marginal zone lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 4th Lyon, France IARC Press 218 219
3. Marcucci F., Mele A., Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 2011 117 6 1792 1798 2-s2.0-79951468929 10.1182/blood-2010-06-275818
4. Suarez F., Lortholary O., Hermine O., Lecuit M., Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006 107 8 3034 3044 2-s2.0-33645051417 10.1182/blood-2005-09-3679
5. Hermine O., Lefrère F., Bronowicki J. P., Mariette X., Jondeau K., Eclache-Saudreau V., Delmas B., Valensi F., Cacoub P., Brechot C., Varet B., Troussard X., Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. New England Journal of Medicine 2002 347 2 89 94 2-s2.0-0037063113 10.1056/NEJMoa013376 (Pubitemid 34753478)
6. Poordad F., McCone J. Jr., Bacon B. R., Bruno S., Manns M. P., Sulkowski M. S., Jacobson I. M., Reddy K. R., Goodman Z. D., Boparai N., DiNubile M. J., Sniukiene V., Brass C. A., Albrecht J. K., Bronowicki J. P., Boceprevir for untreated chronic HCV genotype 1 infection. New England Journal of Medicine 2011 364 13 1195 1206 2-s2.0-79953173221 10.1056/NEJMoa1010494
7. Hézode C., Forestier N., Dusheiko G., Ferenci P., Pol S., Goeser T., Bronowicki J. P., Bourlière M., Gharakhanian S., Bengtsson L., McNair L., George S., Kieffer T., Kwong A., Kauffman R. S., Alam J., Pawlotsky J. M., Zeuzem S., Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. New England Journal of Medicine 2009 360 18 1839 1850 2-s2.0-65449171953 10.1056/NEJMoa0807650
8. Agnello V., Chung R. T., Kaplan L. M., A role for hepatitis C virus infection in Type II cryoglobulinemia. New England Journal of Medicine 1992 327 21 1490 1495 2-s2.0-0026439201
9. Agnello V., Zhang Q. X., Abel G., Knight G. B., The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. Clinical and Experimental Rheumatology 1995 13 supplement 13 S-101 S-104 2-s2.0-0029551799 (Pubitemid 26127942)
10. Ferri C., Zignego A. L., Pileri S. A., Cryoglobulins. Journal of Clinical Pathology 2002 55 1 4 13 2-s2.0-0036143398 (Pubitemid 34081673)
11. Monti G., Pioltelli P., Saccardo F., Campanini M., Candela M., Cavallero G., De Vita S., Ferri C., Mazzaro C., Migliaresi S., Ossi E., Pietrogrande M., Gabrielli A., Galli M., Invernizzi F., Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Archives of Internal Medicine 2005 165 1 101 105 2-s2.0-19944429080 10.1001/archinte.165.1.101 (Pubitemid 40096090)
12. Zignego A. L., Giannelli F., Marrocchi M. E., Giannini C., Gentilini P., Innocenti F., Ferri C., Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases. Clinical and Experimental Rheumatology 1997 15 6 711 712 2-s2.0-0031263305
13. Mazzaro C., Monti G., Saccardo F., Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study. Clinical and Experimental Rheumatology 2011 29 6 933 941
14. Saadoun D., Rigon M. R., Sene D., Terrier B., Karras A., Perard L., Schoindre Y., Coppéré B., Blanc F., Musset L., Piette J. C., Rosenzwajg M., Cacoub P., Rituximab plus Peg-interferon- α /ribavirin compared with Peg-interferon- α /ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 2010 116 3 326 334 2-s2.0-77955857269 10.1182/blood-2009-10-248518
15. Dammacco F., Tucci F. A., Lauletta G., Gatti P., De Re V., Conteduca V., Sansonno S., Russi S., Mariggiò M. A., Chironna M., Sansonno D., Pegylated interferon- α ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood 2010 116 3 343 353 2-s2.0-77954869956 10.1182/blood-2009-10-245878
16. Arcaini L., Lazzarino M., Colombo N., Burcheri S., Boveri E., Paulli M., Morra E., Gambacorta M., Cortelazzo S., Tucci A., Ungari M., Ambrosetti A., Menestrina F., Orsucci L., Novero D., Pulsoni A., Frezzato M., Gaidano G., Vallisa D., Minardi V., Tripodo C., Callea V., Baldini L., Merli F., Federico M., Franco V., Iannitto E., Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 2006 107 12 4643 4649 2-s2.0-33745066935 10.1182/blood-2005-11-4659 (Pubitemid 43882609)
17. Saadoun D., Suarez F., Lefrere F., Valensi F., Mariette X., Aouba A., Besson C., Varet B., Troussard X., Cacoub P., Hermine O., Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005 105 1 74 76 2-s2.0-19944429608 10.1182/blood-2004-05- 1711 (Pubitemid 40053066)
18. Arcaini L., Paulli M., Burcheri S., Rossi A., Spina M., Passamonti F., Lucioni M., Motta T., Canzonieri V., Montanari M., Bonoldi E., Gallamini A., Uziel L., Crugnola M., Ramponi A., Montanari F., Pascutto C., Morra E., Lazzarino M., Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. British Journal of Haematology 2007 136 2 301 304 2-s2.0-33845894185 10.1111/j.1365-2141.2006.06437.x (Pubitemid 46020759)
19. Arcaini L., Burcheri S., Rossi A., Passamonti F., Paulli M., Boveri E., Brusamolino E., Orlandi E., Molteni A., Pulsoni A., Cox M. C., Orsucci L., Fabbri A., Frezzato M., Voso M. T., Zaja F., Montanari F., Pascutto C., Morra E., Cortelazzo S., Lazzarino M., Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. Oncologist 2006 11 3 285 291 2-s2.0-33645080942 10.1634/theoncologist.11-3-285
20. Ferreri A. J. M., Viale E., Guidoboni M., Resti A. G., De Conciliis C., Politi L., Lettini A. A., Sacchetti F., Dolcetti R., Doglioni C., Ponzoni M., Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Annals of Oncology 2006 17 5 769 772 2-s2.0-33646174947 10.1093/annonc/mdl027
21. Paulli M., Arcaini L., Lucioni M., Boveri E., Capello D., Passamonti F., Merli M., Rattotti S., Rossi D., Riboni R., Berti E., Magrini U., Bruno R., Gaidano G., Lazzarino M., Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. Annals of Oncology 2009 21 6 1189 1195 2-s2.0-77951630180 10.1093/annonc/mdp454
22. Tedeschi A., Vismara E., Varettoni M., Clinical and biological implications of hepatitis C virus positivity in waldenstrom's macroglobulinemia patients. 114 Proceedings of the ASH Annual Meeting Abstracts 2009 2934
23. Arcaini L., Varettoni M., Boveri E., Orlandi E., Rattotti S., Zibellini S., Merli M., Lucioni M., Rizzi S., Gotti M., Morello L., Pascutto C., Paulli M., Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma. Clinical Lymphoma, Myeloma and Leukemia 2011 11 1 103 105 2-s2.0-79953675087 10.3816/CLML.2011.n.020
24. Goldaniga M. C., Ferrario A., Cortelazzo S., Guffanti A., Pavone E., Ambrosetti A., Marcheselli L., Rossi F., Luminari S., Rossi A., Cro L., Federico M., Deliliers G. L., Baldini L., A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias. American Journal of Hematology 2008 83 5 349 354 2-s2.0-42949115797 10.1002/ajh.21065 (Pubitemid 351614744)
25. Wasley A., Alter M. J., Epidemiology of hepatitis C: geographic differences and temporal trends. Seminars in Liver Disease 2000 20 1 1 16 2-s2.0-0033916804 (Pubitemid 30421405)
26. Shepard C. W., Finelli L., Alter M. J., Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases 2005 5 9 558 567 2-s2.0-23944506014 10.1016/S1473-3099(05)70216-4 (Pubitemid 41196755)
27. Talamini R., Montella M., Crovatto M., Dal Maso L., Cpispo A., Negri E., Spina M., Pinto A., Carbone A., Franceschi S., Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. International Journal of Cancer 2004 110 3 380 385 2-s2.0-2442419813 10.1002/ijc.20137 (Pubitemid 38649889)
28. Collier J. D., Zanke B., Moore M., Kessler G., Krajden M., Shepherd F., Heathcote J., No association between hepatitis C and B-cell lymphoma. Hepatology 1999 29 4 1259 1261 2-s2.0-0032923307 (Pubitemid 29168763)
29. Gisbert J. P., García-Buey L., Pajares M. J., Moreno-Otero R., Prevalence of hepatitis C virus infection in B-cell non-hodgkin's lymphoma: systematic, review and meta-analysis. Gastroenterology 2003 125 6 1723 1732 2-s2.0-0345490987 10.1053/j.gastro.2003.09.025 (Pubitemid 37500437)
30. Nieters A., Kallinowski B., Brennan P., Ott M., Maynadié M., Benavente Y., Foretova L., Cocco P. L., Staines A., Vornanen M., Whitby D., Boffetta P., Becker N., De Sanjosé S., Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology 2006 131 6 1879 1886 2-s2.0-33845662835 10.1053/j.gastro.2006. 09.019 (Pubitemid 44958516)
31. De Sanjose S., Benavente Y., Vajdic C. M., Engels E. A., Morton L. M., Bracci P. M., Spinelli J. J., Zheng T., Zhang Y., Franceschi S., Talamini R., Holly E. A., Grulich A. E., Cerhan J. R., Hartge P., Cozen W., Boffetta P., Brennan P., Maynadié M., Cocco P., Bosch R., Foretova L., Staines A., Becker N., Nieters A., Hepatitis C and non-hodgkin lymphoma among 4784 cases and 6269 controls from the international lymphoma epidemiology consortium. Clinical Gastroenterology and Hepatology 2008 6 4 451 458 2-s2.0-41349088895 10.1016/j.cgh.2008.02.011 (Pubitemid 351447318)
32. Arcaini L., Burcheri S., Rossi A., Paulli M., Bruno R., Passamonti F., Brusamolino E., Molteni A., Pulsoni A., Cox M. C., Orsucci L., Fabbri A., Frezzato M., Voso M. T., Zaja F., Montanari F., Merli M., Pascutto C., Morra E., Cortelazzo S., Lazzarino M., Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Annals of Oncology 2007 18 2 346 350 2-s2.0-33847305351 10.1093/annonc/mdl388 (Pubitemid 46323104)
33. Tomita N., Kodama F., Takabayashi M., Kawano T., Yamaji S., Fujimaki K., Fujisawa S., Kanamori H., Motomura S., Ishigatsubo Y., Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma. Leukemia and Lymphoma 2003 44 7 1159 1164 2-s2.0-0037648790 10.1080/1042819031000083055 (Pubitemid 36609109)
34. Visco C., Arcaini L., Brusamolino E., Burcheri S., Ambrosetti A., Merli M., Bonoldi E., Chilosi M., Viglio A., Lazzarino M., Pizzolo G., Rodeghiero F., Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Annals of Oncology 2006 17 9 1434 1440 2-s2.0-33748744162 10.1093/annonc/mdl131 (Pubitemid 44400383)
35. Lecuit M., Abachin E., Martin A., Poyart C., Pochart P., Suarez F., Bengoufa D., Feuillard J., Lavergne A., Gordon J. I., Berche P., Guillevin L., Lortholary O., Immunoproliferative small intestinal disease associated with campylobacter jejuni. New England Journal of Medicine 2004 350 3 239 248 2-s2.0-9144227738 10.1056/NEJMoa031887 (Pubitemid 38067636)
36. Roggero E., Zucca E., Mainetti C., Bertoni F., Valsangiacomo C., Pedrinis E., Borisch B., Piffaretti J. C., Cavalli F., Isaacson P. G., Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Human Pathology 2000 31 2 263 268 2-s2.0-0033981024 (Pubitemid 30090662)
37. Ferreri A. J. M., Guidoboni M., Ponzoni M., De Conciliis C., Dell'Oro S., Fleischhauer K., Caggiari L., Lettini A. A., Dal Cin E., Ieri R., Freschi M., Villa E., Boiocchi M., Dolcetti R., Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. Journal of the National Cancer Institute 2004 96 8 586 594 2-s2.0-2342465012 (Pubitemid 38584982)
38. Ferreri A. J. M., Ponzoni M., Guidoboni M., De Conciliis C., Resti A. G., Mazzi B., Lettini A. A., Demeter J., Dell'Oro S., Doglioni C., Villa E., Boiocchi M., Dolcetti R., Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. Journal of Clinical Oncology 2005 23 22 5067 5073 2-s2.0-24644519021 10.1200/JCO.2005.07.083 (Pubitemid 46224014)
39. Arcaini L., Paulli M., Boveri E., Magrini U., Lazzarino M., Marginal zone-related neoplasms of splenic and nodal origin. Haematologica 2003 88 1 80 93 2-s2.0-0037309491 (Pubitemid 36168859)
40. Melo J. V., Hegde U., Parreira A., Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. Journal of Clinical Pathology 1987 40 6 642 651 2-s2.0-0023176805 (Pubitemid 17092847)
41. Melo J. V., Robinson D. S. F., Gregory C., Catovsky D., Splenic B cell lymphoma with 'villous' lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia. Leukemia 1987 1 4 294 298 2-s2.0-0023543424
42. Isaacson P. G., Matutes E., Burke M., Catovsky D., The histopathology of splenic lymphoma with villous lymphocytes. Blood 1994 84 11 3828 3834 2-s2.0-0028073125 (Pubitemid 24362482)
43. Marasca R., Vaccari P., Luppi M., Zucchini P., Castelli I., Barozzi P., Cuoghi A., Torelli G., Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. American Journal of Pathology 2001 159 1 253 261 2-s2.0-0035403970 (Pubitemid 33704210)
44. Armitage J. O., A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997 89 11 3909 3918 2-s2.0-1842413105 (Pubitemid 27220933)
45. Cavalli F., Isaacson P. G., Gascoyne R. D., Zucca E., MALT Lymphomas. Hematology 2001 241 258 2-s2.0-0035232573
46. Thieblemont C., Clinical presentation and management of marginal zone lymphomas. Hematology 2005 307 313 2-s2.0-33645062124
47. Thieblemont C., Berger F., Dumontet C., Moullet I., Bouafia F., Felman P., Salles G., Coiffier B., Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000 95 3 802 806 2-s2.0-0034141533 (Pubitemid 30062699)
48. Thieblemont C., de la Fouchardière A., Coiffier B., Nongastric mucosa-associated lymphoid tissue lymphomas. Clinical Lymphoma 2003 3 4 212 224 2-s2.0-0037357818 (Pubitemid 36416845)
49. Zucca E., Conconi A., Pedrinis E., Cortelazzo S., Motta T., Gospodarowicz M. K., Patterson B. J., Ferreri A. J. M., Ponzoni M., Devizzi L., Giardini R., Pinotti G., Capella C., Zinzani P. L., Pileri S., López-Guillermo A., Campo E., Ambrosetti A., Baldini L., Cavalli F., Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003 101 7 2489 2495 2-s2.0-0037769815 10.1182/blood-2002-04-1279 (Pubitemid 36857603)
50. Coiffier B., Osmanov E. A., Hong X., Scheliga A., Mayer J., Offner F., Rule S., Teixeira A., Walewski J., de Vos S., Crump M., Shpilberg O., Esseltine D. L., Zhu E., Enny C., Theocharous P., van de Velde H., Elsayed Y. A., Zinzani P. L., Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. The Lancet Oncology 2011 12 8 773 784 2-s2.0-79960892918 10.1016/S1470-2045(11)70150-4
51. Luppi M., Longo G., Ferrari M. G., Ferrara L., Marasca R., Barozzi P., Morselli M., Emilia G., Torelli G., Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. British Journal of Haematology 1996 94 2 373 375 2-s2.0-0029901549 (Pubitemid 26247997)
52. Ambrosetti A., Zanotti R., Pattaro C., Lenzi L., Chilosi M., Caramaschi P., Arcaini L., Pasini F., Biasi D., Orlandi E., D'Adda M., Lucioni M., Pizzolo G., Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. British Journal of Haematology 2004 126 1 43 49 2-s2.0-3042789131 10.1111/j.1365-2141.2004.04993.x (Pubitemid 38859480)
53. Ramos-Casals M., La Civita L., De Vita S., Solans R., Luppi M., Medina F., Caramaschi P., Fadda P., De Marchi G., Lopez-Guillermo A., Font J., Brito-Zerón P., Loustaud-Ratti V., Zeher M., Szodoray P., Bosch J. A., Selva-O'Callaghan A., Vilardell M., Toussirot E., Wendling D., Rosas J., Anaya J. M., Forns X., Sanchez-Tapias J., Jara L. J., Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection. Arthritis Care and Research 2007 57 1 161 170 2-s2.0-33847004729 10.1002/art.22476
54. Leleu X., O'Connor K., Ho A. W., Santos D. D., Manning R., Xu L., Hatjiharissi E., Moreau A. S., Branagan A. R., Hunter Z. R., Dimmock E. A., Soumerai J., Palterson C., Ghobrial I., Treon S. P., Hepatitis C viral infection is not associated with Waldenstrom's Macroglobulinemia. American Journal of Hematology 2007 82 1 83 84 2-s2.0-33845940319 10.1002/ajh.20724 (Pubitemid 46033400)
55. Arcaini L., Sacchi P., Jemos V., Lucioni M., Rumi E., Dionigi P., Paulli M., Splenic marginal zone B-cell lymphoma in a HIV-positive patient: a case report. Annals of Hematology 2009 88 4 379 381 2-s2.0-60749097996 10.1007/s00277-008-0587-4
56. Arcaini L., Pascutto C., Passamonti F., Bruno R., Merli M., Rizzi S., Orlandi E., Astori C., Rattotti S., Paulli M., Lazzarino M., Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection. International Journal of Cancer 2009 124 9 2246 2249 2-s2.0-63449101607 10.1002/ijc.24162
57. Matutes E., Owusu-Ankomah K., Morilla R., Garcia Marco J., Houlihan A., Que T. H., Catovsky D., The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994 8 10 1640 1645 2-s2.0-0028149568 (Pubitemid 24323778)
58. Ugo V., Leporrier N., Salaun V., Letestu R., Radford-Weiss I., Ramond S., Nataf J., Guesnu M., Picard F., Brouzes C., Perrot J. Y., Valensi F., Levy V., Ajchenbaum-Cymbalista F., Troussard X., Deciphering leukemic B-cell chronic lymphoproliferative disorders. Leukemia and Lymphoma 2006 47 10 2088 2095 2-s2.0-33750477310 10.1080/10428190600727939 (Pubitemid 44650084)
59. Fried M. W., Shiffman M. L., Rajender Reddy K., Smith C., Marinos G., Goncales J. F. L., Häussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., Yu J., Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine 2002 347 13 975 982 2-s2.0-0037179698 10.1056/NEJMoa020047
60. Hadziyannis S. J., Sette H. Jr., Morgan T. R., Balan V., Diago M., Marcellin P., Ramadori G., Bodenheimer H., Bernstein D., Rizzetto M., Zeuzem S., Pockros P. J., Lin A., Ackrill A. M., Peginterferon- α 2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Annals of Internal Medicine 2004 140 5 346 355 2-s2.0-1542378867
61. Ghany M. G., Strader D. B., Thomas D. L., Seeff L. B., Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009 49 4 1335 1374 2-s2.0-65449136656 10.1002/hep.22759
62. Jesudian A. B., Gambarin-Gelwan M., Jacobson I. M., Advances in the treatment of hepatitis C virus infection. Gastroenterology & Hepatology 2012 8 91 101
63. Bauduer F., MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha. American Journal of Hematology 1996 53 209 (Pubitemid 26377750)
64. Caramaschi P., Biasi D., Carletto A., Ambrosetti A., Mocella S., Randon M., Bambara L. M., Mucosa-associated lymphoid tissue (MALT) lymphoma of salivary glands. Report of a case in a patient with hepatitis C virus infection and review of the literature. Recenti Progressi in Medicina 1999 90 11 585 591 2-s2.0-0033217159
65. Moccia F., Tognoni E., Boccaccio P., The relationship between splenic marginal zone B-cell lymphoma and chronic liver disease associated with hepatitis C virus infection. Annali Italiani di Medicina Interna 1999 14 4 288 293 2-s2.0-0033406837 (Pubitemid 30007166)
66. Patriarca F., Silvestri F., Fanin R., Zaja F., Sperotto A., Baccarani M., Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment. British Journal of Haematology 2001 112 2 370 372 2-s2.0-0035123859 10.1046/j.1365-2141.2001.02571. x (Pubitemid 32183479)
67. Casato M., Mecucci C., Agnello V., Fiorilli M., Knight G. B., Matteucci C., Gao L., Kay J., Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 2002 99 6 2259 2261 2-s2.0-0037085784 10.1182/blood.V99.6.2259 (Pubitemid 34525518)
68. Pitini V., Arrigo C., Righi M., Scaffidi M., Sturniolo G., Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma. British Journal of Haematology 2004 124 2 252 253 2-s2.0-1642539965 10.1046/j.1365-2141.2003.04751.x (Pubitemid 38122201)
69. Tursi A., Brandimarte G., Torello M., Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy. Journal of Clinical Gastroenterology 2004 38 4 360 363 2-s2.0-1642271946 10.1097/00004836-200404000-00011 (Pubitemid 38393073)
70. Kelaidi C., Rollot F., Park S., Tulliez M., Christoforov B., Calmus Y., Podevin P., Bouscary D., Sogni P., Blanche P., Dreyfus F., Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia 2004 18 10 1711 1716 2-s2.0-6344270206 10.1038/sj.leu.2403443 (Pubitemid 39386352)
71. Vallisa D., Bernuzzi P., Arcaini L., Sacchi S., Callea V., Marasca R., Lazzaro A., Trabacchi E., Anselmi E., Arcari A. L., Moroni C., Bertè R., Lazzarino M., Cavanna L., Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. Journal of Clinical Oncology 2005 23 3 468 473 2-s2.0-20044377730 10.1200/JCO.2005.06.008 (Pubitemid 46224223)
72. Svoboda J., Andreadis C., Downs L. H., Miller W. T., Tsai D. E., Schuster S. J., Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection. Leukemia and Lymphoma 2005 46 9 1365 1368 2-s2.0-24644449687 10.1080/104281905001028289 (Pubitemid 41269305)
73. Oda Y., Kou T., Watanabe M., Sakuma Y., Taguchi N., Kato Y., Kudo Y., Yamauchi A., Sugiura Y., Ohashi S., Asada M., Fukunaga T., Kawaguchi K., Ito H., Nakamura T., Yazumi S., Regression of B-cell lymphoma of the liver with hepatitis C virus infection after treatment with pegylated interferon- α and ribavirin. Digestive Diseases and Sciences 2010 55 6 1791 1793 2-s2.0-77954425725 10.1007/s10620-009-0902-5
74. Mauro E., Pedata M., Ermacora A., Mazzaro C., An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin's lymphoma previously treated with interferon. Blood Transfusion 2012 10 1 101 103 10.2450/2011.0006-11
75. Mazzaro C., De Re V., Spina M., Dal Maso L., Festini G., Comar C., Tirelli U., Pozzato G., Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas. British Journal of Haematology 2009 145 2 255 257 2-s2.0-63149193476 10.1111/j.1365-2141.2008.07565.x
76. Gisbert J. P., García-Buey L., Pajares J. M., Moreno-Otero R., Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Alimentary Pharmacology and Therapeutics 2005 21 6 653 662 2-s2.0-16344376229 10.1111/j.1365-2036.2005.02395.x (Pubitemid 40468993)
77. Zuckerman E., Zuckerman T., Sahar D., Streichman S., Attias D., Sabo E., Yeshurun D., Rowe J. M., The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001 97 6 1555 1559 2-s2.0-0035869240 10.1182/blood.V97.6.1555 (Pubitemid 32217215)
78. Paulli M., Arcaini L., Lucioni M., Boveri E., Capello D., Passamonti F., Merli M., Rattotti S., Rossi D., Riboni R., Berti E., Magrini U., Bruno R., Gaidano G., Lazzarino M., Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. Annals of Oncology 2009 21 6 1189 1195 2-s2.0-77951630180 10.1093/annonc/mdp454
79. Iannitto E., Ammatuna E., Tripodo C., Marino C., Calvaruso G., Florena A. M., Montalto G., Franco V., Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment. Hematology Journal 2004 5 6 530 533 2-s2.0-11044231649 10.1038/sj.thj.6200408 (Pubitemid 40045290)
80. Levine A. M., Shimodaira S., Lai M. M. C., Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon alfa. New England Journal of Medicine 2003 349 21 2078 2079 2-s2.0-0344064143 10.1056/ NEJM200311203492121 (Pubitemid 37448938)
81. Ennishi D., Maeda Y., Niitsu N., Kojima M., Izutsu K., Takizawa J., Kusumoto S., Okamoto M., Yokoyama M., Takamatsu Y., Sunami K., Miyata A., Murayama K., Sakai A., Matsumoto M., Shinagawa K., Takaki A., Matsuo K., Kinoshita T., Tanimoto M., Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis. Blood 2010 116 24 5119 5125 2-s2.0-78650074442 10.1182/blood-2010-06-289231
82. Musto P., Dell'Olio M., La Sala A., Mantuano S., Cascavilla N., Diffuse B-large cell lymphomas (DBLCL) with hepatitis-C virus (HCV) infection: clinical outcome and preliminary results of a pilot study combining R-CHOP with antiviral therapy. 106 Proceedings of the ASH Annual Meeting Abstracts 2005 2447
83. La Mura V., De Renzo A., Perna F., D'Agostino D., Masarone M., Romano M., Bruno S., Torella R., Persico M., Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. Journal of Hepatology 2008 49 557 563